Literature DB >> 19381363

Systems biology evaluation of immune responses induced by human host defence peptide LL-37 in mononuclear cells.

Neeloffer Mookherjee1, Pamela Hamill, Jennifer Gardy, Darren Blimkie, Reza Falsafi, Avinash Chikatamarla, David J Arenillas, Silvana Doria, Tobias R Kollmann, Robert E W Hancock.   

Abstract

The immune system is very complex, it involves the integrated regulation and expression of hundreds of proteins. To understand in greater detail how the human host defence immunomodulatory peptide LL-37 interacts with innate immunity, a systems approach was pursued. Polychromatic flow cytometry was employed to demonstrate that within human peripheral blood mononuclear cells, CD14+ monocytes, myeloid and plasmocytoid dendritic cells and T- and B-lymphocytes, all responded to LL-37, with the differential production of intracellular cytokines. Microarray analyses with CD14+ monocytes indicated the differential expression of 475 genes in response to stimulation with LL-37. To understand this complex response, bioinformatic interrogation, using InnateDB, of the gene ontology, signalling pathways and transcription factor binding sites was undertaken. Activation of the IkappaBalpha/NFkappaB, mitogen-activated protein kinases p38, ERK1/2 and JNK, and PI3K signalling pathways in response to LL-37 was demonstrated by pathway and ontology over-representation analyses, and confirmed experimentally by inhibitor studies. Computational analysis of the predicted transcription factor binding sites upstream of the genes that were regulated by LL-37 predicted the involvement of several transcription factors including NFkappaB and five novel factors, AP-1, AP-2, SP-1, E2F1, and EGR, which were experimentally confirmed to respond to LL-37 by performing transcription factor array studies on nuclear extracts from LL-37 treated mononuclear cells. These data are discussed as reflecting the integration of several responsive signalling pathways through the involvement of transcription factor complexes in gene expression activated by LL-37 in human mononuclear cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19381363     DOI: 10.1039/b813787k

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  35 in total

1.  The role of the Src family kinase Lyn in the immunomodulatory activities of cathelicidin peptide LL-37 on monocytic cells.

Authors:  Anastasia Nijnik; Jelena Pistolic; Patricia Cho; Niall C J Filewod; Reza Falsafi; Alexander Ramin; Kenneth W Harder; Robert E W Hancock
Journal:  J Leukoc Biol       Date:  2012-01-13       Impact factor: 4.962

Review 2.  Cationic host defence peptides: multifaceted role in immune modulation and inflammation.

Authors:  Ka-Yee Choi; Leola N Y Chow; Neeloffer Mookherjee
Journal:  J Innate Immun       Date:  2012-03-14       Impact factor: 7.349

3.  Cathelicidin peptide LL-37 modulates TREM-1 expression and inflammatory responses to microbial compounds.

Authors:  Gimano D Amatngalim; Anastasia Nijnik; Pieter S Hiemstra; Robert E W Hancock
Journal:  Inflammation       Date:  2011-10       Impact factor: 4.092

Review 4.  Immune modulation by multifaceted cationic host defense (antimicrobial) peptides.

Authors:  Ashley L Hilchie; Kelli Wuerth; Robert E W Hancock
Journal:  Nat Chem Biol       Date:  2013-12       Impact factor: 15.040

Review 5.  The immunology of host defence peptides: beyond antimicrobial activity.

Authors:  Robert E W Hancock; Evan F Haney; Erin E Gill
Journal:  Nat Rev Immunol       Date:  2016-04-18       Impact factor: 53.106

6.  LL-37 immunomodulatory activity during Mycobacterium tuberculosis infection in macrophages.

Authors:  Flor Torres-Juarez; Albertina Cardenas-Vargas; Alejandra Montoya-Rosales; Irma González-Curiel; Mariana H Garcia-Hernandez; Jose A Enciso-Moreno; Robert E W Hancock; Bruno Rivas-Santiago
Journal:  Infect Immun       Date:  2015-09-08       Impact factor: 3.441

7.  Modulation of Human Beta-Defensin 2 Expression by Pathogenic Neisseria meningitidis and Commensal Lactobacilli.

Authors:  Gabriela M Wassing; Nathalie Ilehag; Jonas Frey; Ann-Beth Jonsson
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

Review 8.  Peptide design for antimicrobial and immunomodulatory applications.

Authors:  Evan F Haney; Robert E W Hancock
Journal:  Biopolymers       Date:  2013-11       Impact factor: 2.505

Review 9.  Alarmins and immunity.

Authors:  Zhen Han; Joost J Oppenheim
Journal:  Immunol Rev       Date:  2017-11       Impact factor: 12.988

10.  Human cathelicidin LL-37 and its derivative IG-19 regulate interleukin-32-induced inflammation.

Authors:  Ka-Yee G Choi; Scott Napper; Neeloffer Mookherjee
Journal:  Immunology       Date:  2014-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.